September 2026– date –

arXiv International Overview A novel framework, DexTouch-WM, successfully learns predictive models for contact-rich dexterous robot manipulation from scalable human tactile data. This model can jointly forecast future RGB observations an...

DRONELIFE USA Overview U.S. battery cell manufacturer Rincell unveiled its NDAA-compliant tabless 21700 lithium-ion cell, 'RC50T,' at DroneX. Designed specifically for drones, this new cell features 100A continuous discharge, 150A pulse ...

EYOU Robot China Overview EYOU Robot inaugurated the world's first automated production line for robot joints in Shanghai in early 2026, marking a significant manufacturing breakthrough. The line boasts an impressive 60-second cycle time...

PNAS (Proceedings of the National Academy of Sciences) Germany Overview Researchers at the University of Stuttgart have developed magnetically actuated ceramic microscrolls with mechanically stored elastic energy, pioneering a new class ...

AllSci USA Overview Envisagenics has partnered with Boehringer Ingelheim in a research and option agreement valued at over $1 billion for RNA splicing-targeted oncology therapeutics. Envisagenics will leverage its AI-driven SpliceCore pl...

Aspen Neuroscience Unknown Overview Aspen Neuroscience announced the publication of preclinical data for Sasineprocel, its investigational autologous iPSC-derived cell therapy for Parkinson's disease, in the prestigious journal Cell Stem...

bioRxiv Unknown Overview A new preprint on bioRxiv, titled "CAR T-cells and is induced by LIF and glucocorticoids," suggests that α2,3-sialylation plays a role in CAR T-cell functional modulation, with induction by LIF and glucocorticoid...

CGTlive® USA Overview The FDA has granted approval to rebisufligene etisparvovec-hopf (Fayuvi), the first gene therapy for pediatric Sanfilippo Syndrome Type A (MPS IIIA). Fayuvi is a one-time intravenous AAV9 gene therapy designed to de...

News-Medical.Net Germany Overview Evotec has established a scalable, xeno-free bioprocess platform for developing immune-evasive and tumor microenvironment (TME)-resistant iPSC-derived CAR γδ T-cells (CAR iγδ T-cells) targeting hepatocel...

EurekAlert! (via Mass General Brigham) USA Overview In a Phase 1 clinical trial led by Mass General Brigham Cancer Institute and the University of Chicago Medicine Comprehensive Cancer Center, the BCMA-targeted CAR-T cell therapy, anitoc...